Introduction
An unexpected FDA inspection can either validate your compliance efforts—or expose costly gaps. Being prepared is not just about documentation; it’s about building a culture of continuous compliance across your pharmaceutical operations. So the question is—are you truly ready?
What Triggers an FDA Inspection?
What the FDA Looks For
Signs You’re Not Ready
How to Stay Inspection-Ready
Conclusion
At Apicule, we help pharmaceutical companies build proactive inspection readiness programs. From training to documentation reviews, our experts ensure that when the FDA walks in, you’re already steps ahead.
IntroductionForced degradation studies are an essential part of pharmaceutical development, providing insight into the stability and shelf life of active pharmaceutical ingredients (APIs) and drug products. These studies simulate extreme... Read more
Pharmaceutical drugs must maintain their potency, safety, and effectiveness throughout their shelf life. Analytical development plays a critical role in assessing and ensuring drug formulation stability. Importance of Analytical Development... Read more
IntroductionA robust Quality Management System (QMS) is the backbone of any GMP-compliant pharmaceutical operation. During supplier or vendor audits, evaluating their QMS is essential to ensure that your sourcing partners... Read more
